Zimmer Biomet Holdings (ZBH) Net Cash Flow (2009 - 2026)

Zimmer Biomet Holdings' Net Cash Flow history runs 18 years deep, the most recent figure standing at -$168.8 million for Q1 2026.

• On a quarterly basis, Net Cash Flow fell 119.81% year-over-year to -$168.8 million in Q1 2026; TTM through Mar 2026 was -$973.6 million, a 197.74% decrease from a year earlier, with the FY2025 full-year figure at $47.4 million, down 62.62% from the prior year.
• Net Cash Flow improved to -$168.8 million in Q1 2026 per ZBH's latest filing, from -$701.6 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $852.2 million in Q1 2025 and bottomed at -$842.4 million in Q2 2025.
• The 5-year median for Net Cash Flow is -$17.1 million (2024), against an average of $6.1 million.
• Biggest YoY gain for Net Cash Flow was 5083.63% in 2025; the steepest drop was 2861.97% in 2025.
• Year by year, Net Cash Flow stood at -$181.7 million in 2022, then soared by 163.95% to $116.2 million in 2023, then tumbled by 121.94% to -$25.5 million in 2024, then plunged by 2651.37% to -$701.6 million in 2025, then surged by 75.94% to -$168.8 million in 2026.
• Per Business Quant, the three latest ZBH Net Cash Flow figures stand at -$168.8 million (Q1 2026), -$701.6 million (Q4 2025), and $739.2 million (Q3 2025).